"Sientra successfully argued that this lawsuit, the 14th consecutive case brought by J&J/Mentor against either Sientra or its employees in the last 18 months..."
Replace "DOT" with ".".
toxic warrants were known before it fell 95% in late August, yet it still fell. Who cares about revenue when costs are 2x revenue and they will run out of cash? No, this has no chance.
How stupid? I am not short this P.O.S. They are going to dilute by 80%. That's what the warrants say. If you don't believe me read the filings.
I don't know what will happen in that case. That wouldn't be ideal certainly. I would like to believe that the European regulators will be able to reach a consensus with the FDA.
The CE mark was revoked on Silimed products sold in Europe. Sientra doesn't need that mark since that's only for European sales and Sientra sells in the US. They stopped selling inventory in the US for marketing reasons.
The rest of the inventory may indeed have the same microscopic particles but if they manage to get the FDA to specifically agree (again?) that they pose no risk after this current round of investigation, Sientra will be selling that inventory.